Literature DB >> 10147109

Payment restrictions for prescription drugs under Medicaid.

R M Schulz1, N J Lewis.   

Abstract

Mesh：

Year:  1992        PMID： 10147109     DOI： 10.2165/00019053-199201030-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245
  1 in total
  2 in total

1.  Economic impact of cost-containment strategies in third party programmes in the US (part I).

Authors:  C E Reeder; E W Lingle; R M Schulz; R P Mauch; B S Nightengale; C A Pedersen; M L Watrous; S E Zetzl
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

2.  The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.

Authors:  R E Johnson; M J Goodman; M C Hornbrook; M B Eldredge
Journal:  Health Serv Res       Date:  1997-04       Impact factor: 3.402
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.